This website uses cookies. For more information please contact us or consult our privacy policy.

Your binder contains too many pages, the maximum is 40.

We are unable to add this page to your binder, please try again later.

This page has been added to your binder.

Regulatory and Product Liability Issues Posed by Pharmacogenomics, Tissue Engineering and Vaccines

March 2005 , British Institute of International and Comparative Law, Pharmaceutical Conference

Share this article: